Time limited offer for new users ▶ Get up to 3 months free

Serving leading biopharmaceutical companies globally:

Last Updated: January 31, 2023

Actavis Elizabeth Company Profile

✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions

What is the competitive landscape for ACTAVIS ELIZABETH, and what generic and branded alternatives to ACTAVIS ELIZABETH drugs are available?

ACTAVIS ELIZABETH has one hundred and sixteen approved drugs.

There are six tentative approvals on ACTAVIS ELIZABETH drugs.

Summary for Actavis Elizabeth

US Patents:	0
Tradenames:	76
Ingredients:	76
NDAs:	116
Patent Litigation for Actavis Elizabeth:	See patent lawsuits for Actavis Elizabeth
PTAB Cases with Actavis Elizabeth as petitioner:	See PTAB cases with Actavis Elizabeth as petitioner

Drugs and US Patents for Actavis Elizabeth

+ Get email alerts for changes to this table

Subscribe to access the full database, or Try it Free
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Actavis Elizabeth	GUANFACINE HYDROCHLORIDE	guanfacine hydrochloride	TABLET, EXTENDED RELEASE;ORAL	200881-004	Oct 5, 2012	AB	RX	No	No		See Plans and Pricing				See Plans and Pricing
Actavis Elizabeth	CLONAZEPAM	clonazepam	TABLET;ORAL	074869-001	Oct 31, 1996	AB	RX	No	No		See Plans and Pricing				See Plans and Pricing
Actavis Elizabeth	ALPRAZOLAM	alprazolam	TABLET, EXTENDED RELEASE;ORAL	078056-001	Feb 13, 2007	AB	RX	No	No		See Plans and Pricing				See Plans and Pricing
Actavis Elizabeth	DOXYCYCLINE HYCLATE	doxycycline hyclate	TABLET, DELAYED RELEASE;ORAL	090134-004	May 22, 2018	AB	RX	No	No		See Plans and Pricing				See Plans and Pricing
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim

Moodys

Baxter

Colorcon

Johnson and Johnson

Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.